Hubbry Logo
HyperreflexiaHyperreflexiaMain
Open search
Hyperreflexia
Community hub
Hyperreflexia
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Hyperreflexia
Hyperreflexia
Hyperreflexia
View on Wikipedia
from Wikipedia
Hyperreflexia
Other namesHyper-reflexia
SpecialtyNeurology

Hyperreflexia is overactive or overresponsive bodily reflexes. Examples of this include twitching and spastic tendencies, which indicate disease of the upper motor neurons and the lessening or loss of control ordinarily exerted by higher brain centers of lower neural pathways.[citation needed]

Spinal cord injury is the most common cause of hyperreflexia.[citation needed] Standard stimuli, such as the filling of the bladder, can cause excessive responses from the nervous system. The causes of hyperreflexia are not known.[citation needed]

Hyperreflexia also has many other causes, including the side effects of drugs (e.g., stimulants), hyperthyroidism, electrolyte imbalance, serotonin syndrome, severe brain trauma, multiple sclerosis, Reye syndrome, and pre-eclampsia.[citation needed]

Recovery from hyperreflexia can occur several hours to several months after a spinal cord injury; the phase of recovery is likely to occur in stages rather than on a continuum.[1] The late stage is between two weeks and several months.[1] Patients with a severe spinal cord injury mainly present with a later stage of recovery because during the early stages they present with spinal shock.[1] Reflex and motor recovery can sometimes occur simultaneously.[1]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Hyperreflexia

View on Grokipedia
from Grokipedia
Hyperreflexia is a neurological defined by the presence of hyperactive or exaggerated deep tendon reflexes in response to stimuli, typically resulting from disruption of pathways that normally inhibit spinal reflex arcs. This overactive reflex response can manifest as brisk muscle contractions upon minimal provocation, such as during a standard patellar tendon tap, and is often accompanied by phenomena like reflex radiation to adjacent muscle groups. The condition arises primarily from lesions or damage to the upper motor neurons in the brain, , or , which interrupt descending inhibitory signals to the and lead to unmodulated reflex hyperactivity. Common causes include cerebrovascular accidents (strokes), , (ALS), traumatic brain or injuries, and other neurodegenerative or inflammatory disorders affecting the . Less commonly, non-neurological factors such as anxiety disorders or can contribute to transient hyperreflexia by enhancing overall excitability. Clinically, hyperreflexia is a key indicator of dysfunction and is evaluated through a involving deep tendon testing, where responses are graded on a scale from 0 (absent) to 4+ (hyperactive with ). Associated symptoms frequently include muscle , weakness, and —rhythmic, involuntary muscle oscillations that further highlight the loss of supraspinal control. While hyperreflexia itself is not a , its identification prompts investigation into underlying pathologies; treatment focuses on managing the root cause, such as through medications for (e.g., ) or therapies for specific conditions like , though progressive disorders like may only allow symptomatic relief.

Definition and Pathophysiology

Definition

Hyperreflexia is characterized by overactive or exaggerated deep tendon reflexes, such as a brisk knee-jerk response, resulting from the loss of supraspinal on spinal arcs. This condition manifests as hyperactive stretch es, often including clonic (repeating) components, due to interrupted descending pathways from higher centers. In essence, it represents an abnormal enhancement of the normal response to muscle stretch, leading to excessive excitability at the spinal level. As a clinical sign, hyperreflexia is indicative of (UMN) dysfunction, where lesions above the level of the spinal disrupt inhibitory signals, thereby unmasking hyperactive segmental reflexes. This contrasts sharply with , which involves diminished or absent reflexes typically due to (LMN) lesions or disruptions within the reflex arc itself, such as in peripheral neuropathies. While signals direct impairment of the efferent or afferent components, hyperreflexia highlights suprasegmental pathology without affecting the peripheral reflex machinery. Spinal cord injury serves as a common trigger for hyperreflexia, often emerging as an early indicator of involvement.

Normal Reflex Arc

The monosynaptic arc represents the simplest neural pathway for rapid muscle responses to mechanical stimuli, involving direct communication between sensory and motor neurons at the level. When a muscle is stretched, specialized sensory receptors called muscle spindles detect the change in length and generate action potentials in Ia afferent fibers, which synapse directly onto alpha motor neurons in the . These alpha motor neurons then transmit signals via efferent pathways to the extrafusal muscle fibers, triggering a contraction that counteracts the stretch and restores muscle length. Higher brain centers, including the and , exert modulatory influence over spinal es through descending pathways that can either facilitate or inhibit the reflex arc. The , originating primarily from the , provides excitatory and inhibitory inputs to spinal and motor neurons, allowing voluntary control and adjustment of reflex sensitivity based on , such as during movement or posture maintenance. Other descending tracts, like the reticulospinal pathway from the , further contribute to this regulation by integrating sensory information and ensuring coordinated motor output. Clinicians grade deep tendon reflexes on a standardized scale from 0 to 4+ to assess normality, with 2+ indicating an average brisk response without , signifying intact reflex function. A grade of 0 denotes absent reflexes, 1+ a diminished response, 3+ increased briskness, and 4+ briskness accompanied by transient . This grading helps establish baseline , where deviations like exaggeration may signal underlying issues such as hyperreflexia.

Mechanisms of Hyperreflexia

Hyperreflexia arises primarily from lesions in the upper motor neurons (UMNs), which disrupt descending inhibitory pathways that normally modulate spinal reflex arcs. These pathways, including the corticospinal and reticulospinal tracts, exert tonic suppression on spinal motor neurons to prevent excessive reflex responses. When UMNs are damaged, this inhibition is lost, resulting in hyperexcitability of alpha motor neurons in the , leading to exaggerated stretch reflexes and brisk deep tendon reflexes. In normal physiology, alpha motor neurons innervate extrafusal muscle fibers for contraction, while gamma motor neurons adjust intrafusal fibers in muscle spindles to maintain sensitivity during movement through alpha-gamma co-activation. Although earlier hypotheses proposed dysregulation of this co-activation as a contributor to hyperexcitability following UMN lesions, studies have not confirmed significant changes in gamma drive; instead, key mechanisms include reduced presynaptic inhibition of Ia afferents, alterations in activity, and intrinsic motoneuron properties such as persistent inward currents that prolong excitatory responses. This neuronal hyperexcitability manifests as spasticity, characterized by a velocity-dependent increase in muscle tone that directly stems from hyperreflexia. The heightened excitability lowers the threshold for stretch reflex activation, causing resistance to passive movement that intensifies with faster stretching velocities due to enhanced Ia afferent firing. Post-injury, hyperreflexia develops in stages following an initial period of spinal shock. Spinal shock begins immediately after acute spinal cord injury, featuring transient areflexia and flaccid paralysis due to sudden loss of descending facilitation and hyperpolarization of spinal neurons below the lesion level. Over weeks to months, reflexes recover as spinal circuits adapt through mechanisms such as denervation supersensitivity, synaptic reorganization, and interneuron hyperexcitability, where reduced GABAergic inhibition allows unchecked excitatory signaling. This transition culminates in hyperreflexia, often accompanied by expansion of motor neuron receptive fields, broadening the area of sensory input that triggers reflexes and further contributing to spastic tone.

Causes

Upper Motor Neuron Lesions

Upper motor neuron (UMN) lesions disrupt the descending pathways from the brain to the , particularly the corticospinal tracts, which normally exert inhibitory control over spinal reflex arcs, leading to hyperreflexia as a hallmark sign below the level of the lesion. These lesions can result from various neurological disorders, manifesting as increased deep tendon reflexes due to the loss of supraspinal modulation on alpha motor neurons and in the . Spinal cord injury (SCI), whether acute traumatic (e.g., from accidents or falls) or non-traumatic (e.g., from ischemia or compression), initially causes —a transient phase of areflexia and below the injury site due to sudden loss of descending input. typically resolves within days to weeks, with an average duration of 4 to 12 weeks, after which hyperreflexia emerges as spinal circuits regain excitability and develop hyperexcitability without supraspinal inhibition. This hyperreflexia is prominent in the limbs below the level and often accompanies , affecting more than 80% of individuals with SCI in the chronic phase. Multiple sclerosis (MS), an autoimmune of the , frequently involves plaques in the corticospinal tracts, leading to UMN dysfunction and hyperreflexia as a common clinical feature. Demyelination impairs conduction along descending motor pathways, resulting in exaggerated reflexes, often alongside other like and weakness. Ischemic or hemorrhagic , as well as severe , can interrupt corticospinal tracts in the or cerebral hemispheres, producing contralateral hyperreflexia that typically develops within the first 4 weeks post-injury as initial resolves. In , occlusion or rupture of vessels supplying motor areas leads to loss of inhibitory descending signals, with hyperreflexia becoming evident in the affected limbs over weeks to months, correlating with the extent of tract damage. Similarly, blunt head trauma damaging the upper motor pathways results in this pattern, often persisting as a chronic UMN sign. Other conditions include (ALS) in its early stages, where degeneration of UMN cells in the can present with hyperreflexia, , and brisk deep tendon reflexes before signs dominate. , resulting from perinatal brain injury to developing motor pathways, also features persistent hyperreflexia as an UMN lesion effect, with increased deep tendon reflexes in the affected extremities due to non-progressive disruption of corticospinal control.

Metabolic and Toxic Causes

Metabolic and toxic causes of hyperreflexia arise from systemic disruptions that heighten neuronal excitability without structural damage to the , often leading to reversible hyperactive deep tendon reflexes. These conditions typically involve imbalances in electrolytes, hormones, or neurotransmitters that lower inhibitory thresholds in the reflex arc, resulting in exaggerated responses to stimuli. Unlike structural lesions, these etiologies respond well to correction of the underlying metabolic or toxic insult, with hyperreflexia resolving upon normalization of the precipitating factor. Hyperthyroidism, characterized by excess thyroid hormone production, is a prominent metabolic cause of hyperreflexia due to increased neuronal excitability from heightened sensitivity to catecholamines and direct effects on neuromuscular junctions. This leads to brisk deep tendon reflexes, often accompanied by and anxiety, as enhance synaptic transmission and reduce inhibitory modulation in the . In clinical studies, hyperreflexia has been observed in approximately 26% of patients with , though it may be more prevalent in untreated or severe cases, serving as a key neurological sign alongside and . Treatment with antithyroid drugs typically restores normal reflex activity by mitigating hormonal excess. Electrolyte imbalances, particularly and hypomagnesemia, contribute to hyperreflexia by destabilizing neuronal membranes and increasing peripheral excitability. In , low serum calcium levels reduce the threshold for generation, promoting spontaneous firing and resulting in hyperactive reflexes, , and positive Chvostek or Trousseau signs; severe cases (serum calcium <7 mg/dL) can manifest with overt hyperreflexia and muscle spasms. Similarly, hypomagnesemia impairs magnesium's role as a natural , leading to heightened neuromuscular , hyperreflexia, and symptoms like tremors or seizures, especially when levels fall below 1.46 mg/dL. These imbalances often stem from , renal losses, or gastrointestinal disorders and are reversible with prompt repletion. Toxic and drug-induced causes frequently involve overstimulation of systems, such as serotonin or sympathomimetics, which amplify arcs through central and peripheral mechanisms. , often triggered by selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors, or their combinations, presents with hyperreflexia—particularly in the lower extremities—due to excessive serotonergic activity causing disinhibition of motor neurons and inducible ; this is a hallmark of moderate to severe cases alongside autonomic instability and altered mental status. overdoses, including amphetamines or , induce hyperreflexia via sympathomimetic excess, which heightens adrenergic signaling and leads to agitation, , and increased as toxicity progresses. Withdrawal states from substances like opioids, alcohol, or similarly provoke hyperreflexia through rebound hyperexcitability in the absence of inhibitory effects, manifesting as tremors, anxiety, and autonomic hyperactivity during acute phases. Discontinuation of the offending agent and supportive care usually alleviate these symptoms. In , represents a unique metabolic-toxic overlap, where and cerebral irritation from and lead to transient hyperreflexia as a sign of neuromuscular irritability. This condition, affecting 2-8% of pregnancies, often features brisk deep tendon reflexes and due to increased sympathetic tone and vascular changes in the , potentially progressing to if untreated. Hyperreflexia in is typically reversible with delivery and antihypertensive management, distinguishing it from chronic neurological disorders.

Clinical Features

Signs and Symptoms

Hyperreflexia manifests primarily as exaggerated deep tendon reflexes in the limbs, graded as 3+ (brisk, increased response) to 4+ (hyperactive, often with ) on the NINDS scale, where normal reflexes fall within 1+ to 2+. These heightened reflexes can lead to involuntary muscle contractions upon minimal stimulation, such as tapping the , and may radiate to adjacent muscle groups, amplifying the response beyond typical bounds. In lesions, this exaggeration is frequently bilateral and symmetric, affecting both sides of the body equally below the level of injury, while supraspinal lesions such as may produce asymmetric hyperreflexia contralateral to the lesion. A key feature is , characterized by sustained rhythmic oscillations of the muscle at a frequency of 5-7 Hz, typically involving more than 10 beats and graded as 5 or documented as 4+ when sustained. This is most commonly observed at the ankles following brisk dorsiflexion, manifesting as repeated plantarflexion movements, but can also occur at the wrists with sudden extension. Clonus arises from the loss of supraspinal inhibition, resulting in repetitive stretch reflexes that patients may notice as uncontrollable jerking during attempts to maintain position. Patients often report or exhibit muscle spasms and due to the overactive reflexes, which can cause sudden flexor or extensor contractions interfering with daily movements like walking or grasping objects. This , while motor in nature, occurs without accompanying , preserving touch, pain, and in the affected areas. Hyperreflexia frequently coexists with in , where exaggerated reflexes contribute to limb rigidity.

Associated Findings

Hyperreflexia often accompanies other pathological signs indicative of (UMN) lesions, such as the Babinski sign, which manifests as an upgoing plantar response upon stimulation of the sole of the foot, reflecting dysfunction. This sign is a hallmark of UMN pathology and is elicited during routine to assess pyramidal tract integrity. Another associated finding is Hoffmann's sign, characterized by involuntary flexion of the thumb and fingers when the middle finger's nail bed is flicked, suggesting cervical involvement or UMN lesions above the level of the lower extremities. It is particularly prevalent in conditions like degenerative cervical myelopathy, where it correlates with and hyperreflexia in the upper limbs. In patients with spinal cord injury (SCI), hyperreflexia frequently co-occurs with comorbidities stemming from UMN syndrome, including due to loss of descending , instability from and impaired coordination, and urinary urgency or retention resulting from detrusor overactivity. These features contribute to overall functional impairment, with often presenting as below the level and disturbances manifesting as a spastic, scissoring pattern. Urinary dysfunction arises from disrupted supraspinal modulation of reflexes, leading to neurogenic symptoms in up to 80% of SCI cases.

Diagnosis

Physical Examination

The physical examination for hyperreflexia primarily involves assessing deep reflexes (DTRs) as part of a comprehensive neurological evaluation to identify exaggerated reflex responses indicative of dysfunction. Clinicians use a to elicit these reflexes by delivering a quick, controlled tap to specific tendons while the patient is relaxed in a seated or , ensuring the muscle is slightly stretched at the time of testing. Common sites include the biceps (C5-C6), triceps (C7), (L3-L4), and (S1), with responses observed for speed, amplitude, and any sustained oscillations. Reflexes are graded on a standardized scale to quantify hyperreflexia, such as the National Institute of Neurological Disorders and Stroke (NINDS) system: 0 indicates absent response (abnormal); 1+ a diminished response (possibly normal); 2+ a normal brisk response; 3+ a brisk and exaggerated response suggesting hyperreflexia; and 4+ an exaggerated response with transient (abnormal). In cases of hyperreflexia, a 3+ or higher grade is typical, often accompanied by rapid and relaxation that exceeds normal limits. This grading helps differentiate hyperreflexia from normal variability and guides further investigation into underlying causes. Clonus, a hallmark of severe hyperreflexia, is elicited by applying sustained dorsiflexion to the ankle using quick upward pressure on the foot while supporting the leg, maintaining tension to provoke rhythmic, involuntary oscillations of the ankle joint. The response is counted in beats; fewer than three beats may be normal, but sustained lasting more than 10 seconds or exceeding five to eight beats signifies significant involvement. Similar testing can be attempted at the or , though ankle clonus is most reliable and commonly assessed. These assessments are integrated into standardized protocols, such as those outlined by the American Academy of Neurology, where bilateral testing of DTRs and is performed to detect , which may point to unilateral hemispheric lesions like those seen in with exaggerated responses on the affected side. is noted by comparing reflex grades and duration between sides, with hyperreflexia typically more pronounced contralaterally to the lesion. The patient should be relaxed, and reinforcements like Jendrassik's maneuver (clenching fists) may be used if initial responses are subdued, ensuring accurate interpretation within the full exam context.

Diagnostic Tests

Diagnostic tests for hyperreflexia primarily involve imaging, electrodiagnostic studies, and laboratory evaluations to identify and confirm underlying (UMN) lesions or metabolic/toxic etiologies, distinguishing them from (LMN) disorders. These investigations build on initial clinical findings of exaggerated deep tendon reflexes and are essential for pinpointing causes such as pathology, demyelination, cerebrovascular events, or systemic imbalances. Magnetic resonance imaging (MRI) of the and is the preferred modality to visualize structural lesions responsible for UMN dysfunction manifesting as hyperreflexia. MRI can detect demyelinating plaques in (MS), which disrupt corticospinal tracts and lead to hyperreflexia, often showing T2-hyperintense lesions in periventricular or the . For acute cerebrovascular events like ischemic strokes affecting motor pathways, (CT) provides rapid assessment of infarcts in the or , where UMN signs including hyperreflexia emerge contralateral to the lesion. In cases of or trauma, MRI reveals cord , hemorrhage, or compressive masses, correlating with ipsilateral or bilateral hyperreflexia below the level of injury. Electromyography (EMG) combined with nerve conduction studies (NCS) helps differentiate UMN from LMN involvement in hyperreflexia. In pure UMN lesions, such as primary lateral sclerosis, EMG typically shows normal findings or minimal changes like occasional fibrillations limited to a few muscles, with no evidence of widespread active denervation (e.g., fibrillations or positive sharp waves) or chronic reinnervation. NCS demonstrate normal motor and sensory conduction velocities and amplitudes, as peripheral nerves remain intact, contrasting with LMN disorders where reduced compound muscle action potentials and denervation patterns predominate. These studies exclude mimics like amyotrophic lateral sclerosis with mixed UMN/LMN features, confirming isolated UMN pathology in hyperreflexia. Blood tests target metabolic and toxic causes of hyperreflexia by assessing systemic derangements that affect neural excitability. Thyroid function tests, including free thyroxine (FT4), free (FT3), and (TSH), are crucial for detecting thyrotoxicosis or , where elevated FT4/FT3 and suppressed TSH correlate with hyperreflexia due to heightened sympathetic activity. panels evaluate imbalances like , which can induce hyperreflexia through effects. For suspected —a toxic cause involving excess serotonergic activity—while direct serotonin levels are not routinely measured, supportive blood tests such as (to detect ) and comprehensive metabolic panels help confirm complications, with relying primarily on clinical criteria including lower extremity hyperreflexia.

Management

Underlying Cause Treatment

Treatment of hyperreflexia focuses on addressing the underlying to potentially resolve or mitigate the reflex hyperactivity, rather than solely managing symptoms. For lesions, interventions target the primary neurological insult, while metabolic causes require correction of biochemical derangements. In (SCI), particularly when hyperreflexia arises from compressive , surgical decompression is indicated to alleviate pressure on the cord, reduce secondary ischemia, and stabilize the spine. Comprehensive rehabilitation, including physical and with stretching and range-of-motion exercises, is implemented early to prevent complications like contractures that exacerbate hyperreflexia. For (MS), disease-modifying therapies such as beta-interferons are employed to suppress immune-mediated , slow lesion progression in the , and thereby limit the development or worsening of hyperreflexia. These agents, approved since the 1990s, reduce relapse rates and evidence of new lesions, contributing to overall neurological stabilization. In cases of stroke causing upper motor neuron dysfunction and hyperreflexia, acute management includes intravenous thrombolysis with alteplase within the standard 4.5-hour window or in extended windows up to 9-24 hours for selected patients based on advanced neuroimaging (e.g., perfusion mismatch), to restore perfusion and minimize infarct expansion. Antiplatelet agents, such as aspirin initiated 24 hours post-thrombolysis, are used to prevent further thrombotic events and limit ongoing damage. Metabolic causes of hyperreflexia, such as , are treated with antithyroid drugs like methimazole or to inhibit synthesis, or for definitive resolution in refractory or severe cases. Hyperreflexia associated with electrolyte imbalances, including , resolves with targeted repletion using hypotonic fluids or -specific infusions to restore and alleviate neuromuscular irritability.

Symptomatic Relief

Symptomatic relief for hyperreflexia focuses on reducing associated , , and muscle stiffness when the underlying cause cannot be treated, aiming to improve comfort and function without addressing the . plays a central role, with , a GABA-B receptor , administered orally or intrathecally to enhance inhibitory in the , thereby decreasing exaggerated reflexes and . Oral is typically started at low doses and titrated to minimize side effects like drowsiness, while intrathecal delivery via implanted pumps provides targeted relief for severe cases, particularly in chronic where systemic effects are undesirable. , a peripheral , acts by inhibiting calcium release from the in , reducing without central nervous system , and is useful for patients intolerant to . Physical therapy offers non-pharmacological options through targeted exercises to lengthen spastic muscles and prevent contractures, combined with strengthening of muscles to promote balanced mobility and reduce hyperactivity. Programs often include passive range-of-motion techniques, for low-impact , and positioning aids to maintain alignment, with evidence showing sustained improvements in scores when performed regularly. For focal hyperreflexia affecting specific muscle groups, type A injections provide localized relief by blocking release at the , temporarily weakening overactive muscles and alleviating localized spasms. Injections are guided by for precision and repeated every 3-6 months as needed, often integrated with to optimize functional outcomes in conditions like post-stroke .

Prognosis and Complications

Recovery Timeline

The recovery timeline for hyperreflexia varies significantly depending on the underlying cause, with distinct patterns observed in conditions such as spinal cord injury (SCI), multiple sclerosis (MS), and stroke. In SCI, the initial phase following injury is characterized by spinal shock, during which areflexia predominates due to temporary loss of spinal reflex activity, typically lasting from hours to several weeks. This areflexic period resolves as spinal circuitry begins to recover, with hyperreflexia emerging thereafter as an upper motor neuron sign. Hyperreflexia often onsets between 1 and 4 weeks post-injury, progressing to hyperactive flexor reflexes and spasms by 1-3 months, and peaking with extensor spasms and more pronounced hyperreflexia around 3-6 months. Beyond this peak, hyperreflexia may stabilize or partially resolve in incomplete injuries, though it often persists chronically in complete cases, with gradual modulation possible over 6-12 months or longer. In MS, hyperreflexia typically follows a fluctuating course tied to the disease's relapsing-remitting nature, where it may intensify during acute inflammatory affecting upper motor neurons and partially remit afterward. Each often leads to incomplete recovery of reflex function, resulting in cumulative worsening over time rather than full resolution; disease-modifying therapies may reduce frequency and support partial remission in some cases. For , hyperreflexia develops subacutely, often within 1-6 weeks post-event as part of evolving , and follows a trajectory of spontaneous motor recovery that peaks in the first 4 weeks before tapering over 6 months. Prevalence of persistent hyperreflexia decreases from about 24% in the first week to 19% at 3 months, indicating resolution or stabilization in many patients, particularly those with milder deficits. In progressive neurodegenerative disorders like (ALS), hyperreflexia generally persists and may worsen as the disease advances, with no significant recovery expected due to ongoing degeneration. Several factors influence the recovery trajectory of hyperreflexia across these etiologies. Lesion level plays a key role in SCI, with cervical injuries generally associated with more severe and prolonged hyperreflexia compared to lower thoracic or lesions due to broader disruption of descending inhibitory pathways. Patient age affects outcomes, as younger individuals tend to exhibit better overall neurological recovery and less progression of , while older age correlates with worsening hyperreflexia over time due to reduced neural plasticity. Early intervention, such as targeted rehabilitation initiated within weeks of , can modulate spinal excitability and promote better reflex recovery by preventing maladaptive changes in neuronal networks. These elements highlight the importance of individualized monitoring, as unresolved hyperreflexia may contribute to complications like contractures if not addressed.

Potential Complications

Hyperreflexia, as a component of , is often accompanied by , which can lead to several complications if not managed effectively. These include resulting from persistent muscle spasms and heightened muscle tone, which may significantly impair . Additionally, prolonged associated with hyperreflexia can cause muscle contractures, where muscles and tendons shorten and stiffen, restricting mobility and potentially leading to deformities. In individuals with spinal cord injuries, hyperreflexia contributes to the risk of , a potentially life-threatening condition characterized by sudden episodes of severe triggered by stimuli below the level of injury. Untreated autonomic dysreflexia can result in serious outcomes such as , , seizures, or even death. Beyond cardiovascular risks, hyperreflexia-related may increase the likelihood of pressure ulcers due to impaired mobility and positioning, potentially progressing to infections or . Other complications encompass fatigue from constant muscle hyperactivity, interference with daily activities such as hygiene and self-care, and secondary musculoskeletal issues like bone fractures, joint subluxations, or heterotopic . In conditions like or , where hyperreflexia is prevalent, these issues can exacerbate overall and necessitate multidisciplinary intervention to mitigate long-term impacts.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK396/
  2. https://www.ncbi.nlm.nih.gov/books/NBK562238/
  3. https://www.ncbi.nlm.nih.gov/books/NBK537305/
  4. https://my.clevelandclinic.org/health/symptoms/24967-hyperreflexia
  5. https://www.ncbi.nlm.nih.gov/books/NBK541028/
  6. https://nba.uth.tmc.edu/neuroscience/m/s3/chapter02.html
  7. https://nba.uth.tmc.edu/neuroscience/m/s3/chapter06.html
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC3009478/
  9. https://www.mdpi.com/1422-0067/26/11/5162
  10. https://www.neurology.org/doi/10.1212/WNL.54.8.1574
  11. https://www.nature.com/articles/3101603
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC12154372/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC3646581/
  14. https://www.ncbi.nlm.nih.gov/books/NBK541082/
  15. https://www.ncbi.nlm.nih.gov/books/NBK448163/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC6218357/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2860542/
  18. https://www.ncbi.nlm.nih.gov/books/NBK499849/
  19. https://musculoskeletalkey.com/spasticity-and-muscle-overactivity-as-components-of-the-upper-motor-neuron-syndrome/
  20. https://www.sciencedirect.com/science/article/pii/S1877065718300599
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC10874326/
  22. https://www.ncbi.nlm.nih.gov/books/NBK556151/
  23. https://www.merckmanuals.com/professional/pediatrics/neurologic-disorders-in-children/cerebral-palsy-cp
  24. https://www.ncbi.nlm.nih.gov/books/NBK537053/
  25. https://www.ncbi.nlm.nih.gov/books/NBK448195/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC9217679/
  27. https://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/electrolyte-disorders/hypocalcemia
  28. https://www.ncbi.nlm.nih.gov/books/NBK430912/
  29. https://www.ncbi.nlm.nih.gov/books/NBK500003/
  30. https://www.ncbi.nlm.nih.gov/books/NBK482377/
  31. https://www.ncbi.nlm.nih.gov/books/NBK430757/
  32. https://www.ncbi.nlm.nih.gov/books/NBK526012/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC10069269/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9108790/
  35. https://www.ncbi.nlm.nih.gov/books/NBK531502/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC7500234/
  37. https://www.ncbi.nlm.nih.gov/books/NBK534862/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC6948104/
  39. https://www.ncbi.nlm.nih.gov/books/NBK519009/
  40. https://www.ncbi.nlm.nih.gov/books/NBK545156/
  41. https://www.aafp.org/pubs/afp/issues/2020/1215/p740.html
  42. https://physicaldiagnosispdx.com/upper-motor-neuron-signs/
  43. https://www.mdpi.com/2075-4426/12/6/968
  44. https://www.ncbi.nlm.nih.gov/books/NBK557589/
  45. https://med.stanford.edu/stanfordmedicine25/the25/tendon.html
  46. https://www.urmc.rochester.edu/MediaLibraries/URMCMedia/neurosurgery/images/5-minute-neuro-exam-handout.pdf
  47. https://neurologicexam.med.utah.edu/adult/cases/html_case02/case02_discussion.html
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC8130660/
  49. https://www.mayoclinic.org/tests-procedures/spasticity-management/about/pac-20395011
  50. https://www.ninds.nih.gov/health-information/disorders/multiple-sclerosis
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC9739865/
  52. https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048536
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC7307608/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC5014602/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC12034236/
  56. https://emedicine.medscape.com/article/2207448-treatment
  57. https://www.ncbi.nlm.nih.gov/books/NBK526037/
  58. https://www.physio-pedia.com/Baclofen_in_the_Treatment_of_Spinal_Cord_Injuries
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC3101828/
  60. https://health.clevelandclinic.org/best-exercises-to-reduce-spasticity
  61. https://www.mdpi.com/1422-0067/22/9/4886
  62. https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-13-118
  63. https://www.frontiersin.org/journals/integrative-neuroscience/articles/10.3389/fnint.2014.00036/full
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC4392691/
  65. https://www.journalofneuropsychiatry.cl/articulo.php?id=13
  66. https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2023.999253/full
  67. https://veritaneuro.com/news/spinal-cord-injury-and-age-does-patient-age-impact-recovery/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC2689156/
  69. https://meridian.allenpress.com/tscir/article/13/1/81/84913/Spasticity-After-Spinal-Cord-Injury-An-Evidence
  70. https://www.ncbi.nlm.nih.gov/books/NBK507869/
  71. https://www.ncbi.nlm.nih.gov/books/NBK482434/
Add your contribution
Related Hubs
User Avatar
No comments yet.